Mark your Calendars for Targeting Phage Therapy 2025
It is a great pleasure to announce the organization of the 8th World Conference on Targeting Phage Therapy on June 10-11, 2025 at DoubleTree by Hilton Berlin Kudamm, Berlin, Germany.
Keynote Speaker 2025: Professor Robert T. Schooley
It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2025, this June in Berlin.First Speakers Lineup 2025
Keynote Speech – Phage Therapy 2030: Getting from here to there
Robert T. SchooleyUniversity of California, San Diego, USA
Bacteriophage Therapy: A Renaissance – From Military Medicine to Civilian Healthcare
Christian WillyAcademic Hospital Bundeswehr Berlin, Germany
Complex Phage Communities Control Gut (im)balances and May Hold the Key to Restore Gut Biosis
Dennis Sandris NielsenUniversity of Copenhagen, Denmark
KlebPhaCol: Novel Gut Phage Order Associated with the Human Gut
Franklin NobregaUniversity of Southampton, United Kingdom
Optimizing the Phage-Bacteria Ratio in Phage Therapy: Metagenomic Insights into Microbial Balance and Dysbiosis
Domenico FrezzaUniversity of Roma Tor Vergata, Italy
Phage defense systems, are they an obstacle for phage therapy?
Stan J.J. BrounsDelft University of Technology, The Netherlands
Biocontrol of Phage Resistance in Pseudomonas Infections – Fitness Trade-Offs Between Phages and Antibiotic Sensitivity
Jumpei FujikiRakuno Gakuen University, Japan
Yersinia Phage Stories: Impact on Phage Therapy
Mikael SkurnikUniversity of Helsinki, Finland
Targeting Tumors with Engineered Phages: A New Frontier in Precision Oncology
Alberto DanielliUniversity of Bologna, Italy
Engineering Phages for Cancer Therapy: Insights into Immune Interactions and Targeting in Ex-Vivo and In-Vivo Models
Alena KaltenbrunnerUniversity of Bologna, Italy
Endolysin B as a New Approach & Archetype in M. Tuberculosis Treatment
Loris RizzelloUniversity of Milan, Italy
Ex vivo pig lung as a new Cystic Fibrosis model for the study of Pseudomonas aeruginosa biofilm infection and phage therapy application
Marco CaforaUniversity of Milan, Italy
Translating phage therapy into the clinic: Recent accomplishments and next challenges
Jeremy BarrMonash University, Australia
Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery
Christian KühnHannover Medical School, Germany
Phage Therapy in Veterinary Medicine: Presentation of First Clinical Trial in Japan
Hidetomo IwanoRakuno Gakuen University, Japan
Bacteriophages Applications in Broiler Farms: Strategies & Perspectives
Sandra SevillaCentro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana, Spain
Phage Therapy in Europe: Legal, Regulatory and Ethic Issues
Barbara BrennerKanzlei BRENNER, Germany
Short Oral Communications 2025
New Insights into Bacteriophage Therapy in Dogs
Eva Maria Kalbhenn, LABOKLIN GmbH & Co. KG, Germany
Biohybrid Composites of Platelet-Rich Fibrin and Gelatin Hydrogel Beads (Nano/Micro) for Targeted Phage Delivery in the Treatment of Infected Wounds
Farzaneh Moghtader, TiPhage, Turkey
Key Dates 2025
Practical Session: How to Produce, Manufacture,
and Bring Phage Products to Market
This session provides a comprehensive and hands-on approach to the entire phage product lifecycle, from laboratory preparation to industrial-scale production and market entry. Experts will address both practical challenges and administrative requirements, ensuring that participants leave with actionable insights.
Key topics include: Technical & Manufacturing Aspects, Regulatory & Administrative Aspects, Business & Market Strategy.
Phage Therapy 2024: Towards Personalized Phage Therapy
The 7th World Conference on Targeting Phage Therapy 2024 on June 20-21 at Corinthia Palace in Malta was a great success. Over 40 presentations on the latest phage research were delivered to an audience of over 100 attendees representing 35 countries. Read more.